A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.
An increase, reported by the Rhode Island Department of Health, sets a threshold of 55 non-fatal overdoses during a seven day period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results